Abbott Laboratories | Patient Daily

Abbott Laboratories

Patient Daily Report | May 22, 2023

Dr. Lakkireddy: 'Assert-IQ ICM is a significant advancement amongst the tools that are currently available for diagnoses of irregular heart rhythms'

Press release submission | Oct 26, 2018

ABBOTT: Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results

Press release submission | Oct 18, 2018

ABBOTT: New Study Shows Abbott's Novel Diagnostic Test has the Potential to Demonstrate Gold Standard Accuracy and Speed, Which Could Help Rule Out Heart Attacks Earlier at the Point of Care

Marian Johns | Nov 17, 2017

Abbott receives approval in Japan for device to treat mitral regurgitation heart disease

Carol Ostrow | Nov 3, 2017

XIENCE implants show benefits in cardiac recovery

Mark Iandolo | Oct 26, 2017

Abbott rolls out new DRG Neurostimulator System to help combat chronic pain

Kathy Adams | Oct 6, 2017

Abbott completes acquisition of Alere

Carol Ostrow | Oct 3, 2017

Freestyle Libre gains FDA approval, ending need to prick finger for glucose testing, Abbott says

Trending

Patient Daily | Oct 9, 2025

Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'

+ Technology/Innovation

Patient Daily News Service | Oct 9, 2025

Babylon Health collapse raises questions about AI claims across industries

Patient Daily | Oct 9, 2025

AI takes center stage at ASCENT ENT conference, reshaping marketing and operations

Patient Daily | Oct 14, 2025

Mackinac Center raises concerns over federal 340B drug pricing program’s market impact